Please login to the form below

Not currently logged in
Email:
Password:

KOLs

This page shows the latest KOLs news and features for those working in and with pharma, biotech and healthcare.

Taming the Monster

Taming the Monster

physicians and KOLs.

Latest news

  • Signal strength Signal strength

    Certainly, as companies seek to build reputation and trust amongst KOLs, medical affairs teams will be central to demonstrating the transparency, scientific rigour and medical accountability that should underpin every communication

  • Harnessing the unrivalled power of key opinion leaders Harnessing the unrivalled power of key opinion leaders

    Indeed, many pharma companies have been shown to wait until phase III has started before approaching KOLs. ... For example, some KOLs may be experts in clinical trial design while others might excel in public speaking.

  • Back to the future Back to the future

    For example, market access and KOL management are secondary to channel management and branding.

  • Connected Healthcare Connected Healthcare

    Despite the inexorable shift to digital, Cello's research has found that information received face-to-face from peers, key opinion leaders (KOLs), pharma sales representatives and sponsored conferences remain the

  • The changing role of the modern MSL The changing role of the modern MSL

    It will also ensure that MSLs are carefully aligned across all customer-facing teams and channels to nurture existing KOL relationships and build new customers across markets. ... Doing so provides a holistic view of the KOL so the MSL knows how to

More from news
Approximately 1 fully matching, plus 109 partially matching documents found.

Latest Intelligence

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for

  • Accelerating diagnosis in rare disease Accelerating diagnosis in rare disease

    Companies can help raise disease awareness by engaging with key opinion leaders (KOLs) and driving impactful campaigns using a multichannel communication approach. ... Scientific meetings are a valued source of learning among HCPs as they allow for

  • A marathon and a sprint A marathon and a sprint

    At Lucid, we did it with oncology KOLs at a European congress. ... Although the congress had over 1, 000 delegates, the experience we created targeted only the top 15 KOLs in the therapy area.

  • Market research

    Healthcare terms - Market research.

  • Medical education

    Healthcare terms - Medical education.

More from intelligence
Approximately 7 fully matching, plus 29 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 4 fully matching, plus 57 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Apex.co.uk Conferences, Events and Exhibition Stands

Apex.co.uk is one of the UK’s leading event and exhibition agencies, specialising in healthcare. We understand your communication goals, whether...

Latest intelligence

No Voice, No Choice
Adelphi Research UK’s insights help to campaign for change in the Mental Health Act...
Island
Pharma’s isolated islands of innovation
With service design and technology often failing the patient, why perspective on improving outcomes need to change...
Uncertainty, austerity and Brexit
What does it mean for the life science sector?...

Infographics